CJC-1295 no DAC / Ipamorelin
$59.99
In stock
Dilution notice
If a compound turns cloudy after it is reconstituted, the cause is almost always the reconstitution solution rather than the compound itself, and non-laboratory-grade solutions are the usual culprit. For this reason, cloudiness cannot be accepted as grounds for a refund unless the reconstitution was done using a laboratory-grade reconstitution solution.
Description
CJC-1295 no DAC + Ipamorelin pairs two peptides associated with different growth-hormone signaling pathways: GHRH and ghrelin receptors. Research on these pathways explores how the pituitary gland releases growth hormone and how those signals vary over time. The research context below draws on studies of the individual components and related GHRH peptides.
Research context
- GHRH-pathway research examines pituitary signaling and nighttime growth-hormone release.¹1
- Ipamorelin research explores the timing and pattern of growth-hormone pulses.²2
- Component research examines distinct receptor pathways involved in growth-hormone release.³3
- Vittone J, et al. Metabolism. 1997;46(1):89–96. DOI:10.1016/S0026-0495(97)90174-8. Study record.
- Gobburu JV, et al. Pharm Res. 1999;16(9):1412–1416. DOI:10.1023/A:1018955126402. PMID:10496658. PubMed.
- Raun K, et al. Eur J Endocrinol. 1998;139(5):552–561. DOI:10.1530/eje.0.1390552. PMID:9849822. PubMed.
Intended use
Research Use Only. Supplied strictly for laboratory research. Not for use in humans or animals, and not for use in foods, drugs, supplements, or diagnostics.
These statements have not been evaluated by the Food and Drug Administration. No claims are made regarding the diagnosis, treatment, cure, or prevention of any disease. Use is restricted to qualified research professionals.
Batch Documentation
Independent Testing History
Review the latest independently tested batch records for this compound.
Keep exploring
